This is a Demo Server. Data inside this system is only for test purpose.
 

Use of Phenytoin, Phenobarbital Carbamazepine, Levetiracetam Lamot-E rigine and Valproate in Pregnancy and Breastfeeding: Risk of Major Malformations, Dose-dependency, Monotherapy vs Polytherapy, Pharmacokinetics and Clinical Implications

dc.contributor.author Kaplan,Y.C.
dc.contributor.author Demir,O.
dc.date.accessioned 2023-11-18T10:07:35Z
dc.date.available 2023-11-18T10:07:35Z
dc.date.issued 2021
dc.description.abstract It is challenging to balance the fetal risks associated with the use of antiepileptic drugs (AEDs) against maternal and fetal risks of seizure worsening, and therefore it is very important to define and distinguish the possible risks entailed by different AEDs. This paper aims to undertake a comprehensive review regarding the possible risks of four classical (phenytoin’ carbamazepine’ phenobarbital’ and valproate) and two newer (lamotrigine and levetiracetam) AEDs during pregnancy. The review focuses on major and organ-specific malformations’ dose-dependent risks’ mono vs polytherapy’ and clinical pharmacokinetics. A discussion regarding the safety of AED use during breastfeeding is also provided. © 2021 Bentham Science Publishers en_US
dc.identifier.citation 7
dc.identifier.doi 10.2174/1570159X19666210211150856
dc.identifier.issn 1570-159X
dc.identifier.scopus 2-s2.0-85119579157
dc.identifier.uri https://doi.org/10.2174/1570159X19666210211150856
dc.identifier.uri http://standard-demo.gcris.com/handle/123456789/7074
dc.language.iso en en_US
dc.publisher Bentham Science Publishers en_US
dc.relation.ispartof Current Neuropharmacology en_US
dc.rights info:eu-repo/semantics/openAccess en_US
dc.subject Antiepileptics en_US
dc.subject Breastfeeding en_US
dc.subject Carbamazepine en_US
dc.subject Lamotrigine en_US
dc.subject Levetiracetam en_US
dc.subject Major malformations en_US
dc.subject Phenobarbital en_US
dc.subject Phenytoin en_US
dc.subject Pregnancy en_US
dc.subject Valproate en_US
dc.title Use of Phenytoin, Phenobarbital Carbamazepine, Levetiracetam Lamot-E rigine and Valproate in Pregnancy and Breastfeeding: Risk of Major Malformations, Dose-dependency, Monotherapy vs Polytherapy, Pharmacokinetics and Clinical Implications en_US
dc.type Review en_US
dspace.entity.type Publication
gdc.bip.impulseclass C5
gdc.bip.influenceclass C5
gdc.bip.popularityclass C5
gdc.description.department Izmir Institute of Technology İYTE en_US
gdc.description.departmenttemp Kaplan Y.C., Terafar - Izmir Katip Celebi University Teratology Information, Training and Research Center, Izmir, Turkey, Izmir Katip Celebi University School of Medicine, Department of Pharmacology Izmir, Turkey, Izmir University of Economics Faculty of Medicine, Izmir, Turkey; Demir O., University of Health Sciences, Izmir Tepecik Training and Research Hospital, Teratology Information Center, Izmir, Turkey en_US
gdc.description.issue 11 en_US
gdc.description.publicationcategory Diğer en_US
gdc.description.volume 19 en_US
gdc.identifier.pmid PubMed:33573557
gdc.opencitations.count 14
gdc.plumx.crossrefcites 2
gdc.plumx.mendeley 59
gdc.plumx.pubmedcites 6
gdc.plumx.scopuscites 14
gdc.scopus.citedbycount 22
gdc.sobiad.citedbycount 0

Files

Collections